Levorid-D (Levocetirizine Hydrochloride and Phenylephrine Hydrochloride Tablets)
clearskypharmacy
190 views
20 slides
Jan 13, 2022
Slide 1 of 20
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
About This Presentation
Levorid-D Tablets (Levocetirizine Hydrochloride and Phenylephrine Hydrochloride Tablets) are used for the relief of the symptoms of allergic rhinitis such as sneezing, rhinorrhoea, nasal congestion, itching and lacrimation. It should be administered when both the antihistamine properties of Levocet...
Levorid-D Tablets (Levocetirizine Hydrochloride and Phenylephrine Hydrochloride Tablets) are used for the relief of the symptoms of allergic rhinitis such as sneezing, rhinorrhoea, nasal congestion, itching and lacrimation. It should be administered when both the antihistamine properties of Levocetirizine and the nasal decongestant activity of Phenylephrine are desired.
The dosage of Levorid-D tablets (Levocetirizine Hydrochloride
and Phenylephrine Hydrochloride Tablets) is given below:
Adults and Adolescents (12 years and above):
One tablet twice daily. The recommended dosage should not be
exceeded.
URL: https://www.clearskypharmacy.biz/original-levorid-d.html
Levorid-D Tablets (Levocetirizine Hydrochloride
and Phenylephrine Hydrochloride Tablets) have
to be stored at controlled room temperature i.e.
from 20°C to 25°C (68°F to 77°F) with excursions
permitted between 15° to 30°C (59° to 86°F).
Keep this as well as all other medicines away
from children and pets.
URL: https://www.clearskypharmacy.biz/original-levorid-d.html
The use of this medicine is not recommended in children aged less than 6 years
since this formulation does not allow for appropriate dose adaptation.
Comparative clinical trials have revealed no evidence that Levocetirizine
Hydrochloride at the recommended dose impairs mental alertness, reactivity or the
ability to drive. In clinical trials the occurrence of somnolence, fatigue and asthenia
has been reported in some patients under therapy with Levocetirizine
Hydrochloride. Patients should be cautioned against engaging in hazardous
occupations requiring complete mental alertness and motor coordination, such as
operating machinery or driving a motor vehicle, after ingestion of Levocetirizine
Hydrochloride.
Concurrent use of Levocetirizine Hydrochloride with alcohol or other central
nervous system (CNS) depressants should be avoided because additional reductions
in alertness and additional impairment of CNS performance may occur.
URL: https://www.clearskypharmacy.biz/original-levorid-d.html
Urinary retention has been reported post-marketing with Levocetirizine
Hydrochloride. Levocetirizine should be used with caution in patients with
predisposing factors of urinary retention (e.g. spinal cord lesion, prostatic
hyperplasia) as Levocetirizine may increase the risk of urinary retention.
Discontinue, if urinary retention occurs.
Care must be taken in the use of Phenylephrine Hydrochloride in patients with
ischaemic heart disease since agonists at alpha1-adrenoceptors may produce
coronary vasospasm.
In patients with chronic pulmonary hypertension and right ventricular failure,
using Phenylephrine to increase right ventricular coronary perfusion pressure by
increasing the aortic blood pressure leads to detrimental effects on the right
ventricular function and is not recommended.
URL: https://www.clearskypharmacy.biz/original-levorid-d.html
Phenylephrine Hydrochloride must be used with caution in patients with occlusive
vascular disease including Raynaud's Phenomenon.
In cirrhosis, there is a reduction in vascular alpha-adrenergic responsiveness and larger
doses of Phenylephrine may be required for any desired effect.
Concurrent administration of monoamine oxidase inhibitors is an absolute
contraindication.
Severe or unpredictable increases in blood pressure may occur if the patient is receiving
concurrent treatment with a monoamine oxidase inhibitor drug as a result of increased
receptor sensitivity.
Since Phenylephrine has actions that promote smooth muscle contractility, including in
the uterus, and may induce umbilical vasospasm, it should be avoided in pregnancy.
Phenylpehrine should not be administered concomitantly with tricyclic antidepressants
and in patients with hypertension, unstable angina and recent myocardial infarction, and
hyperthyroidism.
URL: https://www.clearskypharmacy.biz/original-levorid-d.html